Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 778 across all filing types
Latest filing 2014-12-11 Report Publication Anno…
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
MAUNA KEA TECHNOLOGIES ANNOUNCES ITS 2015 FINANCIAL CALENDAR
Report Publication Announcement Classification · 99% confidence The document is titled "MAUNA KEA TECHNOLOGIES ANNOUNCES ITS 2015 FINANCIAL CALENDAR" and explicitly lists the dates for future financial events, including the '2014 Full-Year Results' and the 'Annual General Meeting'. Since the document's primary purpose is to announce *when* future reports and meetings will occur, rather than containing the full content of those reports (like a 10-K or IR), it fits the definition of a Report Publication Announcement (RPA). The document length (2912 chars) is short, supporting the idea that it is an announcement rather than the full report itself. Although it mentions the AGM date, the core content is the schedule of publications.
2014-12-11 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Share Issue/Capital Change Classification · 95% confidence The document is titled "Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references the French Commercial Code (Article L233-8-II) and the General Regulation of the AMF (Autorité des Marchés Financiers). It provides a table detailing the number of shares and voting rights as of November 30, 2014. This type of mandatory periodic disclosure regarding the total number of shares and voting rights is a standard regulatory filing in France, often related to capital structure transparency, but it does not fit perfectly into the defined categories like 10-K, ER, or DIV. Since it is a specific regulatory disclosure concerning share capital and voting rights that doesn't match a more specific code (like DVA for voting *results* or SHA for a *change* announcement), the most appropriate fallback category is Regulatory Filings (RNS), as it is a required regulatory report that doesn't fit the other specific definitions.
2014-12-05 French
Rapport des commissaires aux comptes sur le rapport du Président
Audit Report / Information Classification · 99% confidence The document explicitly states it is the "Rapport des commissaires aux comptes" (Report of the Statutory Auditors) concerning the report established by the Chairman of the Board of Directors, referencing specific articles of the French Commercial Code (L. 225-235 and L. 225-37). This document details the auditors' observations on internal control and risk management procedures related to financial reporting. This content aligns perfectly with the definition of an Audit Report / Information (AR), which covers standalone audit reports and applied accounting principles, distinct from the full Annual Report (10-K). The document is the report itself, not an announcement of a report. FY 2013
2014-12-01 French
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Share Issue/Capital Change Classification · 95% confidence The document is titled "Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references the French Commercial Code and the General Regulation of the Autorité des Marchés Financiers (AMF). It provides a table detailing the number of shares and total voting rights as of October 31, 2014. This content directly relates to the structure of the share capital and voting rights, which is a specific regulatory disclosure in France. While it is a periodic report on capital structure, it is not a general capital change announcement (SHA) or a director's dealing (DIRS). It is a specific regulatory disclosure concerning voting rights and share capital structure, which fits best under the general regulatory filing category (RNS) as there is no specific code for 'Monthly Voting Rights Disclosure' among the provided options, or potentially a highly specific interpretation of Capital/Financing Update (CAP) or Share Issue/Capital Change (SHA). However, given the focus on the *total number of voting rights* and the AMF regulation reference, it is a mandatory regulatory disclosure. Since RNS is the fallback for miscellaneous regulatory filings, and this is a specific periodic disclosure not covered by other codes like DIV, NAV, or SHA (which usually implies issuance/buyback), RNS is the most appropriate general regulatory classification.
2014-11-05 French
MAUNA KEA TECHNOLOGIES ET SIEMENS ANNONCENT LEUR COLLABORATION POUR ÉVALUER L’UTILISATION DU CELLVIZIO® EN RADIOLOGIE INTERVENTIONNELLE
Regulatory Filings Classification · 95% confidence The document is a press release dated November 3, 2014, announcing a collaboration between Mauna Kea Technologies and Siemens Healthcare regarding clinical trials for the Cellvizio® platform in Interventional Radiology. It details the scope of the collaboration, quotes key personnel, and provides company background information, including contact details and forward-looking statements. This format is characteristic of a general corporate announcement or news release, which does not fit the specific definitions for financial reports (10-K, IR, ER), shareholder materials (DEF 14A, PSI), or specific transaction reports (CAP, DIV, POS). Since it is a general announcement about business development and clinical evaluation, and it is not a formal regulatory filing like an 8-K or a specific report, the most appropriate general category is 'Regulatory Filings' (RNS) as a fallback for miscellaneous corporate news, although 'LTR' (Legal Proceedings Report) or 'RPA' (Report Publication Announcement) are less fitting. Given the nature of a press release announcing a partnership and clinical evaluation, 'RNS' (Regulatory Filings/General Announcement) is the best fit among the provided options for non-standard corporate news.
2014-11-03 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 95% confidence The document is a press release dated October 21, 2014, announcing positive study results regarding the use of the Cellvizio platform for diagnosing benign pancreatic cysts. It details findings published in a peer-reviewed journal (*Endoscopy*) and mentions presentations at various congresses. This type of announcement, focusing on clinical study outcomes, scientific publications, and general company news that is not a formal regulatory filing (like 10-K, IR, or ER), best fits the category for general corporate news or announcements that don't fit other specific categories. Since it is not a formal financial report, a management discussion, or a specific regulatory filing, it falls under the general Regulatory Filings/Announcements category (RNS) or potentially an Investor Presentation (IP) if it were a slide deck, but as a press release detailing research, RNS is the most appropriate general classification for non-standard announcements.
2014-10-21 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.